Evidence map›Paper›PMID 37116126›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Efficacy and safety in patients treated with a novel radiofrequency balloon: a two centres experience from the AURORA collaboration.

Stefano Bordignon, Ilaria My, Shota Tohoku, Andreas Rillig, David Schaack, Shaojie Chen, Bruno Reißmann, Lukas Urbanek, Jun Hirokami, Tolga Efe and 6 more

Abstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Radiofrequency balloon ablation: 1-year outcomes of the AURORA study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  2. Article
  3. Review
  4. Shortened radiofrequency delivery time to optimize efficiency and safety of pulmonary vein isolation with the radiofrequency balloon: insights from the COLLABORATE registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  5. State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Review
  6. Article
  7. Laser light in the era of pulsed field ablation - still a competitor?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  8. Article
  9. Article
  10. Outcomes of pulmonary vein isolation with radiofrequency balloon vs. cryoballoon ablation: a multi-centric study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Stefano BordignonMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0002-0282-4658
Ilaria MyUniversitäres Herz- und Gefäßzentrum - Klinik für Kardiologie - Universitätsklinikum Hamburg-Eppendorf, Germany.ORCID 0000-0002-1676-4633
Shota TohokuMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0002-0299-362X
Andreas RilligMedizinische Klinik 3 - Universitätsklinikum der Goethe Universität, Frankfurt, Germany.ORCID 0000-0003-3457-0936
David SchaackMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0003-4188-3447
Shaojie ChenMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.
Bruno ReißmannMedizinische Klinik 3 - Universitätsklinikum der Goethe Universität, Frankfurt, Germany.ORCID 0000-0002-0290-6231
Lukas UrbanekMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0002-5234-744X
Jun HirokamiMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0001-5588-0533
Tolga EfeMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0001-6015-9679
Ramin EbrahimiMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.
Mahi ButtUniversitäres Herz- und Gefäßzentrum - Klinik für Kardiologie - Universitätsklinikum Hamburg-Eppendorf, Germany.
Feifan OuyangUniversitäres Herz- und Gefäßzentrum - Klinik für Kardiologie - Universitätsklinikum Hamburg-Eppendorf, Germany.
Julian K R ChunMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0002-2355-6015
Andreas MetznerUniversitäres Herz- und Gefäßzentrum - Klinik für Kardiologie - Universitätsklinikum Hamburg-Eppendorf, Germany.ORCID 0000-0002-6818-6396
Boris SchmidtMedizinische Klinik III, CCB am Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.ORCID 0000-0001-5347-9906

Funding

Biosense WebsterEuropean Heart Rhythm Association
6 · The paper itself

Abstract

aimsA novel irrigated radiofrequency (RF) balloon (RFB) for pulmonary vein (PV) isolation (PVI) was released in selected centres. We pooled the procedural data on efficacy and safety of RFB-PVI from two high volume German centres. METHODS AND

resultsConsecutive patients with RFB procedures were enrolled. A 3D electroanatomical left atrial map guided the RFB navigation. Every RF delivery lasted 60 s, and duration was automatically reduced to 20 s for electrodes facing the posterior wall. Procedural data and post-procedural endoscopy data (<48 h) were analysed. Data from 140 patients were collected (57% male, 67 ± 11 years, 57% paroxysmal atrial fibrillation). There were 547 PVs identified, and 99.1% could be isolated using solely the RFB. Single-shot PVI was recorded in 330/547 (60%) PVs. Median time to isolation during the first application was 10 s (IQR 8-13). A total of 2.1 ± 1.8 applications per PV were delivered, with the left superior PV requiring more application compared to other PVs. Median procedure and fluoroscopy time were 77 min (61-99) and 13 min (10-17), respectively. Major safety events were recorded only in the first 25 cases at each centre and included 1/140(0.7%) cardiac tamponade, 1/140(0.7%) phrenic nerve palsy, and 2/140 strokes (1.4%). An oesophageal temperature rise was recorded in 81/547 (15%) PVs, and endoscopy detected oesophageal lesions in 7/85 (8%) patients undergoing endoscopy.

conclusionThe RFB showed a high efficacy allowing for fast PVI procedures, and 60% of PVs could be isolated at the first application. Most safety events were recorded during the learning phase. An oesophageal temperature monitoring is suggested: oesophageal lesions were detected in 8% of patients.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsFemaleHeart AtriaHumansMaleTreatment OutcomeAblationAtrial FibrillationBalloonRadiofrequency

Identifiers

PMID37116126
PMCPMC10228597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.